英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
atara查看　atara　在百度字典中的解释百度英翻中〔查看〕
atara查看　atara　在Google字典中的解释Google英翻中〔查看〕
atara查看　atara　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Allogeneic T-cell Immunotherapy Company - Atara Biotherapeutics
    Atara is an allogeneic T-cell immunotherapy company We're harnessing the natural biology of T cells—our body’s most effective weapon in fighting disease—to develop transformative therapies for patients with cancer and autoimmune conditions
  • T-Cell Immunotherapy Technology Platform - Atara Biotherapeutics
    Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases
  • Pipeline - Atara Biotherapeutics
    Atara Biotherapeutics’s robust, late-stage pipeline features a host of potentially transformative T-cell immunotherapies for cancer, autoimmune and viral diseases
  • Atara Biotherapeutics (ATRA)
    Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly delivered to patients from inventory
  • Tab-cel - Atara Biotherapeutics
    Tab-cel®, Atara's most advanced T-cell immunotherapy in development, is a potential treatment for patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD), as well as other EBV associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC)
  • Technology - Atara Biotherapeutics
    As a leading allogeneic T-cell immunotherapy company, Atara is pioneering the development of transformative therapies for patients with serious diseases by leveraging our novel allogeneic Epstein Barr virus (EBV) T-cell platform
  • Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 . . .
    About Atara Biotherapeutics, Inc Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly delivered to patients from inventory
  • Atara Biotherapeutics Provides Regulatory Updates on EBVALLO . . .
    Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly delivered to patients from inventory
  • Off-the-shelf, allogeneic CAR T targeting CD19 Atara Biotherapeutics
    Atara internal unpublished data; Curran KJ, et al ASH 2023; ATA3219 ATA3219 is an allogeneic anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, currently in clinical development, leveraging the EBV T-cell platform and features a next-generation 1XX co-stimulatory domain, memory phenotype, and unedited T-cell receptor
  • Press Releases :: Atara Biotherapeutics (ATRA)
    Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress





中文字典-英文字典  2005-2009